Chemoinformaics analysis of 2-hydroxy terephthalic acid
Molecular Weight | 182.131 | nRot | 2 |
Heavy Atom Molecular Weight | 176.083 | nRig | 8 |
Exact Molecular Weight | 182.022 | nRing | 1 |
Solubility: LogS | -2.502 | nHRing | 0 |
Solubility: LogP | 1.936 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 21.3708 |
nHD | 3 | BPOL | 7.75524 |
QED | 0.628 |
Synth | 1.687 |
Natural Product Likeliness | 0.252 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.111 |
CACO-2 | -5.816 |
MDCK | 0.00000744 |
BBB | 0.277 |
PPB | 0.518636 |
VDSS | 0.292 |
FU | 0.426639 |
CYP1A2-inh | 0.024 |
CYP1A2-sub | 0.042 |
CYP2c19-inh | 0.038 |
CYP2c19-sub | 0.031 |
CYP2c9-inh | 0.12 |
CYP2c9-sub | 0.047 |
CYP2d6-inh | 0.025 |
CYP2d6-sub | 0.05 |
CYP3a4-inh | 0.027 |
CYP3a4-sub | 0.011 |
CL | 1.445 |
T12 | 0.939 |
hERG | 0.05 |
Ames | 0.017 |
ROA | 0.109 |
SkinSen | 0.271 |
Carcinogencity | 0.011 |
EI | 0.936 |
Respiratory | 0.474 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.813658 |